{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:57:21Z","timestamp":1740117441727,"version":"3.37.3"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vascn.2024.107527","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T16:41:40Z","timestamp":1717864900000},"page":"107527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone"],"prefix":"10.1016","volume":"128","author":[{"given":"Theresa M.","family":"Bartko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Lutgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline A.","family":"Walisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Garske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry R.","family":"Kopelke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Ashcroft-Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Friedrichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill V.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2024.107527_bb0005","article-title":"ICH E14\/S7B implementation working group: E14\/S7B questions and answers: Clinical and nonclinical evaluation of QT\/QTc interval prolongation and Proarrhythmic potential","author":"Anonymous","year":"2022","journal-title":"Training Materials"},{"key":"10.1016\/j.vascn.2024.107527_bb0010","series-title":"Poster session presentation at the meeting of the safety pharmacology society","article-title":"Heart rate corrected JTp and TpTe as proarrhythmia biomarkers in safety pharmacology non-human primate studies: Outcome from a HESI consortium prospective study","author":"Authier","year":"2023"},{"key":"10.1016\/j.vascn.2024.107527_bb0015","series-title":"Poster session presentation at the meeting of the safety pharmacology society","article-title":"JTpeak assessment in ambulatory dog and monkey an update from the HESI working group","author":"Authier","year":"2022"},{"issue":"6","key":"10.1016\/j.vascn.2024.107527_bb0020","first-page":"846","article-title":"Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens","volume":"18","author":"Brien","year":"1990","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.vascn.2024.107527_bb0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1039\/C4MD00148F","article-title":"Species differences in drug plasma protein binding","volume":"5","author":"Colclough","year":"2014","journal-title":"Medicinal Chemistry Communications"},{"issue":"0","key":"10.1016\/j.vascn.2024.107527_bb0030","first-page":"1","article-title":"The new S7B\/E14 Q&A document provides additional opportunities to replace the thorough QT study","volume":"0","author":"Darpo","year":"2023","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2024.107527_bb0035","series-title":"Comprehensive electrocardiography","first-page":"1909","article-title":"The mammalian electrocardiogram: Comparative features","author":"Detweiler","year":"2010"},{"issue":"5","key":"10.1016\/j.vascn.2024.107527_bb0040","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(87)80320-0","article-title":"Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity","volume":"9","author":"Greenberg","year":"1987","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.vascn.2024.107527_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.vascn.2005.04.019","article-title":"Non-drug-related electrocardiographic features in animal models in safety pharmacology","volume":"52","author":"Hamlin","year":"2005","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"7","key":"10.1016\/j.vascn.2024.107527_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-121-7-199410010-00009","article-title":"Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia","volume":"121","author":"Hohnloser","year":"1994","journal-title":"Annals of Internal Medicine"},{"author":"International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals For Human Use, S7B","key":"10.1016\/j.vascn.2024.107527_bb0055"},{"issue":"5","key":"10.1016\/j.vascn.2024.107527_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/clpt.2013.238","article-title":"Improving the assessment of heart toxicity for all new drugs through translational regulatory science","volume":"95","author":"Johannesen","year":"2014","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.vascn.2024.107527_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.vascn.2024.107527_bb0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: Randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2024.107527_bb0075","doi-asserted-by":"crossref","first-page":"106606","DOI":"10.1016\/j.vascn.2019.106606","article-title":"Exposure-response analysis of drug-induced QT interval prolongation in telemetered monkeys for translational prediction to human","volume":"99","author":"Komatsu","year":"2019","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107527_bb0080","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: Superior to the HERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.vascn.2024.107527_bb0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jphs.2018.01.009","article-title":"Effects of moxifloxacin on the proarrhythmic surrogate markers in healthy filipino subjects: Exposure-response modeling using ECG data of thorough QT\/QTc study","volume":"136","author":"Matsukura","year":"2018","journal-title":"Journal of Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.vascn.2024.107527_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1254\/jphs.FP0040512","article-title":"Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation\/reperfusion-induced arrhythmia model: Comparison with other class III antiarrhythmic drugs","volume":"97","author":"Nagasawa","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2024.107527_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-7843.2006.pto_394.x","article-title":"The effect of levosimendan during long-term amiodarone treatment in dogs","volume":"99","author":"Papp","year":"2006","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107527_bb0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovascular Research"},{"year":"2013","series-title":"Electrocardiography of laboratory animals","author":"Richig","key":"10.1016\/j.vascn.2024.107527_bb0105"},{"key":"10.1016\/j.vascn.2024.107527_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107270","article-title":"Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14\/S7B Q&As","volume":"123","author":"Rossman","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"Suppl. B","key":"10.1016\/j.vascn.2024.107527_bb0115","first-page":"69","article-title":"Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: A comparison in humans and other mammalian species","volume":"43","author":"Siefert","year":"1999","journal-title":"Clinical and Translational Science"},{"issue":"3","key":"10.1016\/j.vascn.2024.107527_bb0120","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jcph.1534","article-title":"Effects of the fluoroquinolones moxifloxacin and levofloxacin on the QT subintervals: Sex differences in ventricular repolarization","volume":"60","author":"T\u00e4ubel","year":"2020","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2024.107527_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107265","article-title":"Improving the in vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute","volume":"121","author":"Vargas","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"6","key":"10.1016\/j.vascn.2024.107527_bb0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jelectrocard.2017.08.003","article-title":"Electrocardiographic biomarkers to confirm drug\u2019s electrophysiological effects used for proarrhythmic risk prediction under CiPA","volume":"50","author":"Vicente","year":"2017","journal-title":"Journal of Electrocardiology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107527_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00005344-199003000-00022","article-title":"Differential effects of amiodarone and desethylamiodarone on calcium antagonist receptors","volume":"15","author":"Wagner","year":"1990","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"4","key":"10.1016\/j.vascn.2024.107527_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjp.2008.287","article-title":"Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues","volume":"155","author":"Waldhauser","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.vascn.2024.107527_bb0145","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1253\/circj.66.758","article-title":"Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model","volume":"66","author":"Yoshida","year":"2002","journal-title":"Circulation Journal"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T22:12:23Z","timestamp":1737756743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871924000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"alternative-id":["S1056871924000376"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107527","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107527"}}